StockData
Baxter International Inc logo

Baxter International Inc (BAX) stock

BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$26.16+0.40 (+1.55%)

Close on Nov 18, 2026Market cap $13.53BP/E –Yield 1.99%

Baxter International revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Baxter International's revenue for the twelve months ending Sep 30, 2026 was $11.61B, up 5.3% year over year. For fiscal 2025 it was $11.24B, up 5.7% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is $13.94B in fiscal 2012.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.24B+5.7%
FY2024Dec 31, 2024$10.64B+2.7%
FY2023Dec 31, 2023$10.36B+3.0%
FY2022Dec 31, 2022$10.06B-17.2%
FY2021Dec 31, 2021$12.15B+4.1%
FY2020Dec 31, 2020$11.67B+2.7%
FY2019Dec 31, 2019$11.36B+2.4%
FY2018Dec 31, 2018$11.10B+4.9%
FY2017Dec 31, 2017$10.58B+4.1%
FY2016Dec 31, 2016$10.16B+2.0%
FY2015Dec 31, 2015$9.97B-7.0%
FY2014Dec 31, 2014$10.72B+13.9%
FY2013Dec 31, 2013$9.41B-32.5%
FY2012Dec 31, 2012$13.94B+0.3%
FY2011Dec 31, 2011$13.89B+8.2%
FY2010Dec 31, 2010$12.84B+2.2%
FY2009Dec 31, 2009$12.56B+1.7%
FY2008Dec 31, 2008$12.35B+9.6%
FY2007Dec 31, 2007$11.26B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.98B+5.0%
Q2 FY2026Jun 30, 2026$2.96B+5.3%
Q1 FY2026Mar 31, 2026$2.70B+2.9%
Q4 FY2025Dec 31, 2025$2.97B+8.0%
Q3 FY2025Sep 30, 2025$2.84B+5.0%
Q2 FY2025Jun 30, 2025$2.81B+4.3%
Q1 FY2025Mar 31, 2025$2.63B+5.4%
Q4 FY2024Dec 31, 2024$2.75B+0.9%
Q3 FY2024Sep 30, 2024$2.70B+3.8%
Q2 FY2024Jun 30, 2024$2.69B+4.0%
Q1 FY2024Mar 31, 2024$2.49B+2.0%
Q4 FY2023Dec 31, 2023$2.73B-27.1%
Q3 FY2023Sep 30, 2023$2.60B-28.0%
Q2 FY2023Jun 30, 2023$2.59B-27.9%
Q1 FY2023Mar 31, 2023$2.44B-31.4%
Q4 FY2022Dec 31, 2022$3.75B+30.2%
Q3 FY2022Sep 30, 2022$3.61B+11.9%
Q2 FY2022Jun 30, 2022$3.59B+16.0%
Q1 FY2022Mar 31, 2022$3.56B+20.8%
Q4 FY2021Dec 31, 2021$2.88B-9.6%
Q3 FY2021Sep 30, 2021$3.23B+8.5%
Q2 FY2021Jun 30, 2021$3.10B+14.0%
Q1 FY2021Mar 31, 2021$2.95B+5.1%
Q4 FY2020Dec 31, 2020$3.18B+4.7%
Q3 FY2020Sep 30, 2020$2.97B+4.2%
Q2 FY2020Jun 30, 2020$2.72B-4.1%
Q1 FY2020Mar 31, 2020$2.80B+6.2%
Q4 FY2019Dec 31, 2019$3.04B+7.3%
Q3 FY2019Sep 30, 2019$2.85B+3.3%
Q2 FY2019Jun 30, 2019$2.83B+0.7%
Q1 FY2019Mar 31, 2019$2.64B-2.0%
Q4 FY2018Dec 31, 2018$2.83B+2.1%
Q3 FY2018Sep 30, 2018$2.76B+2.0%
Q2 FY2018Jun 30, 2018$2.81B+8.0%
Q1 FY2018Mar 31, 2018$2.69B+8.8%
Q4 FY2017Dec 31, 2017$2.77B+4.9%
Q3 FY2017Sep 30, 2017$2.71B–
Q2 FY2017Jun 30, 2017$2.61B–
Q1 FY2017Mar 31, 2017$2.48B–
Q4 FY2016Dec 31, 2016$2.65B–

More Baxter International figures

See a number that looks wrong?